Terms ending in 2029

The Institut Pasteur

Every in-force patent on The Institut Pasteur's record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.

Patent	Title	Holder	Status	Expires	Confidence
US 9,273,094	Opiorphin Peptide Derivatives as Potent Inhibitors of Enkephalin-Degrading Ectopeptidases Institut Pasteur In force Term ends Apr 7, 2029 · Medium confidence	Institut Pasteur	In force	Term ends Apr 7, 2029	Medium confidence
US 10,584,330	Ob-Fold Used as Scaffold for Engineering New Specific Binders Institut Pasteur and Centre National de la Recherche Scientifique In force Term ends Apr 10, 2029 · Medium confidence	Institut Pasteur and Centre National de la Recherche Scientifique	In force	Term ends Apr 10, 2029	Medium confidence
US 8,158,413	Lentiviral Vector-Based Vaccine Institut Pasteur, Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale In force Term ends Jun 4, 2029 · High confidence	Institut Pasteur, Centre National de la Recherche Scientifique and Institut National de la Sante et de la Recherche Medicale	In force	Term ends Jun 4, 2029	High confidence
US 8,460,888	Variable Domains of Camelid Heavy-Chain Antibodies Directed Against Glial Fibrillary Acidic Proteins Institut Pasteur and Centre National de la Recherche Scientifique (CNRS) In force Term ends Jul 7, 2029 · High confidence	Institut Pasteur and Centre National de la Recherche Scientifique (CNRS)	In force	Term ends Jul 7, 2029	High confidence
US 9,387,260	VHH Antibodies Used as Peptide Vectors for Delivering a Substance of Interest Institut Pasteur and Centre National de la Recherche Scientifique In force Term ends Jul 7, 2029 · High confidence	Institut Pasteur and Centre National de la Recherche Scientifique	In force	Term ends Jul 7, 2029	High confidence
US 10,155,054	Variable Domains of Camelid Heavy-Chain Antibodies Directed Against Glial Fibrillary Acidic Proteins Centre National de la Recherche Scientifique (CNRS In force Term ends Jul 10, 2029 · Medium confidence	Centre National de la Recherche Scientifique (CNRS	In force	Term ends Jul 10, 2029	Medium confidence
US 8,927,699	Methods for Obtaining Thermostable Enzymes, Dna Polymerase I Variants from Thermus Aquaticus Having New Catalytic Activities, Methods for Obtaining the Same, and Applications to the Same Institut Pasteur and Centre National de la Recherche Scientifique (CNRS) In force Ends no later than Sep 14, 2029 · Low confidence	Institut Pasteur and Centre National de la Recherche Scientifique (CNRS)	In force	Ends no later than Sep 14, 2029	Low confidence
US 8,906,634	Monitoring and Inhibiting Human Immunodeficiency Virus Infection by Modulating HMGB1 Dependent Triggering of HIV-1 Replication and Persistence Institut Pasteur In force Term ends Sep 16, 2029 · High confidence	Institut Pasteur	In force	Term ends Sep 16, 2029	High confidence
US 9,164,103	Monitoring and Inhibiting Human Immunodeficiency Virus Infection by Modulating HMGB1 Dependent Triggering of HIV-1 Replication and Persistence Institut Pasteur In force Term ends Oct 24, 2029 · Medium confidence	Institut Pasteur	In force	Term ends Oct 24, 2029	Medium confidence
US 8,420,104	Lentiviral Gene Transfer Vectors and Their Medicinal Applications Institut Pasteur, Theravectys and Centre National de la Recherche Scientifique (CNRS) In force Term ends Oct 26, 2029 · High confidence	Institut Pasteur, Theravectys and Centre National de la Recherche Scientifique (CNRS)	In force	Term ends Oct 26, 2029	High confidence
3 more term ends in 2029 · Pro

10 of 13 patents shown. Soonest term end first, then patent number.

Pro members see all 13.

Upgrade to Pro

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.